CLINICAL CANCER RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=565035, encodeId=aa9b565035ab, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:29:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558753, encodeId=e465558e5378, content=ccr本来就没有cr文章多 cr已经成为了很多aacr会员的灌水刊物虽然我这么说不合适对于我们来说cr难度不算大但是绝不轻松sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, beContent=sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 11:24:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558677, encodeId=a5c95586e7a9, content=这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, beContent=载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556088, encodeId=e7d655608884, content=请问下这个杂志要先主编审了修改后再送外审么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Wed May 16 00:00:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555429, encodeId=173355542968, content=审稿速度:1.0 经验分享：投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=381f1659720, createdName=Pis, createdTime=Thu Apr 26 17:33:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842560, encodeId=99f184256018, content=stage start date decision sent to author 2017-02-22 16:39:09 under review 2017-02-21 13:20:04 under editorial consideration 2017-02-21 12:18:45 initial qc 2017-02-19 07:46:50 转投拒稿真的快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baad5414143, createdName=ms493637184140865, createdTime=Tue Apr 24 10:45:25 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554441, encodeId=a7035544412c, content=@小骞大修后有送审么？现在文章什么状态了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Mon Apr 02 08:56:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554313, encodeId=1f3455431371, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:56:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554312, encodeId=d9c65543122a, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:55:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：好贵啊 Standard Fees The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. Cancer Discovery Publication fee: $2,500 for all article types Color fee: $450 per figure. Cancer Research, Clinical Cancer Research Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) Color fee: $675 per figure. Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) Color fee: $625 per figure. Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) Color fee: $625 per figure. No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=)]

2019-01-01 biocell160

revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据

193 0

[GetPortalCommentsPageByObjectIdResponse(id=565035, encodeId=aa9b565035ab, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:29:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558753, encodeId=e465558e5378, content=ccr本来就没有cr文章多 cr已经成为了很多aacr会员的灌水刊物虽然我这么说不合适对于我们来说cr难度不算大但是绝不轻松sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, beContent=sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 11:24:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558677, encodeId=a5c95586e7a9, content=这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, beContent=载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556088, encodeId=e7d655608884, content=请问下这个杂志要先主编审了修改后再送外审么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Wed May 16 00:00:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555429, encodeId=173355542968, content=审稿速度:1.0 经验分享：投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=381f1659720, createdName=Pis, createdTime=Thu Apr 26 17:33:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842560, encodeId=99f184256018, content=stage start date decision sent to author 2017-02-22 16:39:09 under review 2017-02-21 13:20:04 under editorial consideration 2017-02-21 12:18:45 initial qc 2017-02-19 07:46:50 转投拒稿真的快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baad5414143, createdName=ms493637184140865, createdTime=Tue Apr 24 10:45:25 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554441, encodeId=a7035544412c, content=@小骞大修后有送审么？现在文章什么状态了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Mon Apr 02 08:56:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554313, encodeId=1f3455431371, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:56:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554312, encodeId=d9c65543122a, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:55:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：好贵啊 Standard Fees The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. Cancer Discovery Publication fee: $2,500 for all article types Color fee: $450 per figure. Cancer Research, Clinical Cancer Research Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) Color fee: $675 per figure. Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) Color fee: $625 per figure. Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) Color fee: $625 per figure. No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=)]

2018-07-02 bigapple001

ccr本来就没有cr文章多 cr已经成为了很多aacr会员的灌水刊物虽然我这么说不合适对于我们来说cr难度不算大但是绝不轻松sunliang 2018-06-30 发表::
这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢

sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢

284 0

[GetPortalCommentsPageByObjectIdResponse(id=565035, encodeId=aa9b565035ab, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:29:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558753, encodeId=e465558e5378, content=ccr本来就没有cr文章多 cr已经成为了很多aacr会员的灌水刊物虽然我这么说不合适对于我们来说cr难度不算大但是绝不轻松sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, beContent=sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 11:24:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558677, encodeId=a5c95586e7a9, content=这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, beContent=载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556088, encodeId=e7d655608884, content=请问下这个杂志要先主编审了修改后再送外审么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Wed May 16 00:00:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555429, encodeId=173355542968, content=审稿速度:1.0 经验分享：投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=381f1659720, createdName=Pis, createdTime=Thu Apr 26 17:33:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842560, encodeId=99f184256018, content=stage start date decision sent to author 2017-02-22 16:39:09 under review 2017-02-21 13:20:04 under editorial consideration 2017-02-21 12:18:45 initial qc 2017-02-19 07:46:50 转投拒稿真的快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baad5414143, createdName=ms493637184140865, createdTime=Tue Apr 24 10:45:25 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554441, encodeId=a7035544412c, content=@小骞大修后有送审么？现在文章什么状态了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Mon Apr 02 08:56:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554313, encodeId=1f3455431371, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:56:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554312, encodeId=d9c65543122a, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:55:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：好贵啊 Standard Fees The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. Cancer Discovery Publication fee: $2,500 for all article types Color fee: $450 per figure. Cancer Research, Clinical Cancer Research Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) Color fee: $675 per figure. Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) Color fee: $625 per figure. Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) Color fee: $625 per figure. No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=)]

2018-06-30 sunliang

这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢载入灵魂 2018-06-27 00:34:00 发表:
过10分了.可喜可贺!

载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!

303 0

[GetPortalCommentsPageByObjectIdResponse(id=565035, encodeId=aa9b565035ab, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:29:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558753, encodeId=e465558e5378, content=ccr本来就没有cr文章多 cr已经成为了很多aacr会员的灌水刊物虽然我这么说不合适对于我们来说cr难度不算大但是绝不轻松sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, beContent=sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 11:24:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558677, encodeId=a5c95586e7a9, content=这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, beContent=载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556088, encodeId=e7d655608884, content=请问下这个杂志要先主编审了修改后再送外审么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Wed May 16 00:00:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555429, encodeId=173355542968, content=审稿速度:1.0 经验分享：投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=381f1659720, createdName=Pis, createdTime=Thu Apr 26 17:33:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842560, encodeId=99f184256018, content=stage start date decision sent to author 2017-02-22 16:39:09 under review 2017-02-21 13:20:04 under editorial consideration 2017-02-21 12:18:45 initial qc 2017-02-19 07:46:50 转投拒稿真的快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baad5414143, createdName=ms493637184140865, createdTime=Tue Apr 24 10:45:25 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554441, encodeId=a7035544412c, content=@小骞大修后有送审么？现在文章什么状态了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Mon Apr 02 08:56:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554313, encodeId=1f3455431371, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:56:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554312, encodeId=d9c65543122a, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:55:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：好贵啊 Standard Fees The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. Cancer Discovery Publication fee: $2,500 for all article types Color fee: $450 per figure. Cancer Research, Clinical Cancer Research Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) Color fee: $675 per figure. Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) Color fee: $625 per figure. Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) Color fee: $625 per figure. No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=)]

2018-05-16 Sunstar7488

请问下这个杂志要先主编审了修改后再送外审么?

333 0

[GetPortalCommentsPageByObjectIdResponse(id=565035, encodeId=aa9b565035ab, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:29:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558753, encodeId=e465558e5378, content=ccr本来就没有cr文章多 cr已经成为了很多aacr会员的灌水刊物虽然我这么说不合适对于我们来说cr难度不算大但是绝不轻松sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, beContent=sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 11:24:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558677, encodeId=a5c95586e7a9, content=这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, beContent=载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556088, encodeId=e7d655608884, content=请问下这个杂志要先主编审了修改后再送外审么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Wed May 16 00:00:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555429, encodeId=173355542968, content=审稿速度:1.0 经验分享：投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=381f1659720, createdName=Pis, createdTime=Thu Apr 26 17:33:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842560, encodeId=99f184256018, content=stage start date decision sent to author 2017-02-22 16:39:09 under review 2017-02-21 13:20:04 under editorial consideration 2017-02-21 12:18:45 initial qc 2017-02-19 07:46:50 转投拒稿真的快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baad5414143, createdName=ms493637184140865, createdTime=Tue Apr 24 10:45:25 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554441, encodeId=a7035544412c, content=@小骞大修后有送审么？现在文章什么状态了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Mon Apr 02 08:56:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554313, encodeId=1f3455431371, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:56:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554312, encodeId=d9c65543122a, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:55:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：好贵啊 Standard Fees The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. Cancer Discovery Publication fee: $2,500 for all article types Color fee: $450 per figure. Cancer Research, Clinical Cancer Research Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) Color fee: $675 per figure. Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) Color fee: $625 per figure. Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) Color fee: $625 per figure. No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=)]

2018-04-26 Pis

审稿速度:1.0
经验分享：投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。
Decision Sent to Author 2017-12-12 09:45:27
Under Review 2017-11-06 11:09:57
Under Editorial Consideration 2017-11-06 10:02:41
Initial QC 2017-11-06 06:43:44
Manuscript Submission 2017-11-05 23:29:37

225 0

[GetPortalCommentsPageByObjectIdResponse(id=565035, encodeId=aa9b565035ab, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:29:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558753, encodeId=e465558e5378, content=ccr本来就没有cr文章多 cr已经成为了很多aacr会员的灌水刊物虽然我这么说不合适对于我们来说cr难度不算大但是绝不轻松sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, beContent=sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 11:24:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558677, encodeId=a5c95586e7a9, content=这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, beContent=载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556088, encodeId=e7d655608884, content=请问下这个杂志要先主编审了修改后再送外审么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Wed May 16 00:00:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555429, encodeId=173355542968, content=审稿速度:1.0 经验分享：投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=381f1659720, createdName=Pis, createdTime=Thu Apr 26 17:33:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842560, encodeId=99f184256018, content=stage start date decision sent to author 2017-02-22 16:39:09 under review 2017-02-21 13:20:04 under editorial consideration 2017-02-21 12:18:45 initial qc 2017-02-19 07:46:50 转投拒稿真的快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baad5414143, createdName=ms493637184140865, createdTime=Tue Apr 24 10:45:25 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554441, encodeId=a7035544412c, content=@小骞大修后有送审么？现在文章什么状态了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Mon Apr 02 08:56:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554313, encodeId=1f3455431371, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:56:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554312, encodeId=d9c65543122a, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:55:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：好贵啊 Standard Fees The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. Cancer Discovery Publication fee: $2,500 for all article types Color fee: $450 per figure. Cancer Research, Clinical Cancer Research Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) Color fee: $675 per figure. Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) Color fee: $625 per figure. Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) Color fee: $625 per figure. No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=)]

2018-04-24 ms493637184140865

stage start date
decision sent to author 2017-02-22 16:39:09
under review 2017-02-21 13:20:04
under editorial consideration 2017-02-21 12:18:45
initial qc 2017-02-19 07:46:50
转投拒稿真的快

83 0

[GetPortalCommentsPageByObjectIdResponse(id=565035, encodeId=aa9b565035ab, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:29:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558753, encodeId=e465558e5378, content=ccr本来就没有cr文章多 cr已经成为了很多aacr会员的灌水刊物虽然我这么说不合适对于我们来说cr难度不算大但是绝不轻松sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, beContent=sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 11:24:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558677, encodeId=a5c95586e7a9, content=这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, beContent=载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556088, encodeId=e7d655608884, content=请问下这个杂志要先主编审了修改后再送外审么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Wed May 16 00:00:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555429, encodeId=173355542968, content=审稿速度:1.0 经验分享：投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=381f1659720, createdName=Pis, createdTime=Thu Apr 26 17:33:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842560, encodeId=99f184256018, content=stage start date decision sent to author 2017-02-22 16:39:09 under review 2017-02-21 13:20:04 under editorial consideration 2017-02-21 12:18:45 initial qc 2017-02-19 07:46:50 转投拒稿真的快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baad5414143, createdName=ms493637184140865, createdTime=Tue Apr 24 10:45:25 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554441, encodeId=a7035544412c, content=@小骞大修后有送审么？现在文章什么状态了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Mon Apr 02 08:56:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554313, encodeId=1f3455431371, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:56:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554312, encodeId=d9c65543122a, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:55:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：好贵啊 Standard Fees The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. Cancer Discovery Publication fee: $2,500 for all article types Color fee: $450 per figure. Cancer Research, Clinical Cancer Research Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) Color fee: $675 per figure. Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) Color fee: $625 per figure. Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) Color fee: $625 per figure. No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=)]

2018-04-02 Sunstar7488

@小骞大修后有送审么？现在文章什么状态了？

347 0

[GetPortalCommentsPageByObjectIdResponse(id=565035, encodeId=aa9b565035ab, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:29:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558753, encodeId=e465558e5378, content=ccr本来就没有cr文章多 cr已经成为了很多aacr会员的灌水刊物虽然我这么说不合适对于我们来说cr难度不算大但是绝不轻松sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, beContent=sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 11:24:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558677, encodeId=a5c95586e7a9, content=这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, beContent=载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556088, encodeId=e7d655608884, content=请问下这个杂志要先主编审了修改后再送外审么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Wed May 16 00:00:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555429, encodeId=173355542968, content=审稿速度:1.0 经验分享：投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=381f1659720, createdName=Pis, createdTime=Thu Apr 26 17:33:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842560, encodeId=99f184256018, content=stage start date decision sent to author 2017-02-22 16:39:09 under review 2017-02-21 13:20:04 under editorial consideration 2017-02-21 12:18:45 initial qc 2017-02-19 07:46:50 转投拒稿真的快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baad5414143, createdName=ms493637184140865, createdTime=Tue Apr 24 10:45:25 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554441, encodeId=a7035544412c, content=@小骞大修后有送审么？现在文章什么状态了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Mon Apr 02 08:56:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554313, encodeId=1f3455431371, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:56:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554312, encodeId=d9c65543122a, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:55:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：好贵啊 Standard Fees The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. Cancer Discovery Publication fee: $2,500 for all article types Color fee: $450 per figure. Cancer Research, Clinical Cancer Research Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) Color fee: $675 per figure. Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) Color fee: $625 per figure. Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) Color fee: $625 per figure. No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=)]

2018-03-29 03582

请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救

355 0

[GetPortalCommentsPageByObjectIdResponse(id=565035, encodeId=aa9b565035ab, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:29:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558753, encodeId=e465558e5378, content=ccr本来就没有cr文章多 cr已经成为了很多aacr会员的灌水刊物虽然我这么说不合适对于我们来说cr难度不算大但是绝不轻松sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, beContent=sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 11:24:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558677, encodeId=a5c95586e7a9, content=这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, beContent=载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556088, encodeId=e7d655608884, content=请问下这个杂志要先主编审了修改后再送外审么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Wed May 16 00:00:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555429, encodeId=173355542968, content=审稿速度:1.0 经验分享：投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=381f1659720, createdName=Pis, createdTime=Thu Apr 26 17:33:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842560, encodeId=99f184256018, content=stage start date decision sent to author 2017-02-22 16:39:09 under review 2017-02-21 13:20:04 under editorial consideration 2017-02-21 12:18:45 initial qc 2017-02-19 07:46:50 转投拒稿真的快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baad5414143, createdName=ms493637184140865, createdTime=Tue Apr 24 10:45:25 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554441, encodeId=a7035544412c, content=@小骞大修后有送审么？现在文章什么状态了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Mon Apr 02 08:56:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554313, encodeId=1f3455431371, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:56:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554312, encodeId=d9c65543122a, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:55:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：好贵啊 Standard Fees The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. Cancer Discovery Publication fee: $2,500 for all article types Color fee: $450 per figure. Cancer Research, Clinical Cancer Research Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) Color fee: $675 per figure. Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) Color fee: $625 per figure. Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) Color fee: $625 per figure. No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=)]

2018-03-29 03582

请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救

295 0

[GetPortalCommentsPageByObjectIdResponse(id=565035, encodeId=aa9b565035ab, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:29:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558753, encodeId=e465558e5378, content=ccr本来就没有cr文章多 cr已经成为了很多aacr会员的灌水刊物虽然我这么说不合适对于我们来说cr难度不算大但是绝不轻松sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, beContent=sunliang 2018-06-30 发表:: 这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 11:24:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558677, encodeId=a5c95586e7a9, content=这个杂志才发文量900篇?感觉不太可能啊.cancer research一年2000多篇呢载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, beContent=载入灵魂 2018-06-27 00:34:00 发表: 过10分了.可喜可贺!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556088, encodeId=e7d655608884, content=请问下这个杂志要先主编审了修改后再送外审么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Wed May 16 00:00:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555429, encodeId=173355542968, content=审稿速度:1.0 经验分享：投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=381f1659720, createdName=Pis, createdTime=Thu Apr 26 17:33:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842560, encodeId=99f184256018, content=stage start date decision sent to author 2017-02-22 16:39:09 under review 2017-02-21 13:20:04 under editorial consideration 2017-02-21 12:18:45 initial qc 2017-02-19 07:46:50 转投拒稿真的快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baad5414143, createdName=ms493637184140865, createdTime=Tue Apr 24 10:45:25 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554441, encodeId=a7035544412c, content=@小骞大修后有送审么？现在文章什么状态了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Mon Apr 02 08:56:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554313, encodeId=1f3455431371, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:56:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554312, encodeId=d9c65543122a, content=请问文章是怎么投稿的CCR 我连ACRR的账号都注册不了它总是提示to prove you are a human ，大家注册账号遇到这样的问题了么求救, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/3a10d593db9c5bb5c582727687ebecaf/eb34573eface8befa5851102a5081d4e.jpg, createdBy=c6962066999, createdName=03582, createdTime=Thu Mar 29 22:55:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：好贵啊 Standard Fees The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. Cancer Discovery Publication fee: $2,500 for all article types Color fee: $450 per figure. Cancer Research, Clinical Cancer Research Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) Color fee: $675 per figure. Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) Color fee: $625 per figure. Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) Color fee: $625 per figure. No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=)]

2018-03-22 120583eam68(暂无昵称)

审稿速度:6.0 | 投稿命中率:25.0
经验分享：好贵啊
Standard Fees

The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below.

Cancer Discovery
Publication fee: $2,500 for all article types
Color fee: $450 per figure.

Cancer Research, Clinical Cancer Research
Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types)
Color fee: $675 per figure.

Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics
Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types)
Color fee: $625 per figure.

Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research
Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types)
Color fee: $625 per figure.

No fees will be charged for certain invited article types solicited directly by an editor.

277 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务